Replies to post #76789 on Decision Diagnostics Corp (DECN)

[Scotttrader80]

Who ever leaked the SEC suspension to the markets causing an entity to sell 6 Million shares Thursday afternoon is in a lot of doo doo

Grap some popcorn this drama may be on Netflix soon

[IPwatcher]

From all my reading, I think the science is there, the possibility that they were successful in creating and completing (technology perfected) the test strips with accurate results is there and that they fully expect the test kits to pass USA lab testing

From my reading, your reading of this is completely wrong I am afraid.
SARS COV2 virions simply aren't usually found in the blood (except in the extreme cases of really severe infections and symptomatic illness). So you won't detect them there. Certainly not in asymptomatic infection spreaders.
It is therefore a logical impossibility that DECN would have data that would satisfy the FDA on such a test. Because it would not to possible to generate such data without invoking a significant element of research fraud.

The technique cited in the 'Non inear impedance...' paper COULD be used to detect virus particles (The authors used 1mM KCL solution to demonstrate this) BUT only at concentrations significantly in excess of 1x1-^11 Vp/ml. The authors state this themselves as a FUNDAMENTAL lower limit of detection.

This is about 1000 times higher than the concentration found in the upper respiratory tract mucus (Mucus, not blood is where the virus particles ARE present in the case of infection btw) of SEVERE infections and millions of times higher than that found in mild infections that are picked up by PCR analysis.

DECN COULD go looking for antibodies in blood. But these tests already exist and are being marketed by others. So its hard to see what USP DECN would have there to justify their hype.

None of what DECN have said... or more rightly 'implied' about their claimed tests stands up to technical scrutiny, and they have published precisely zero evidence in terms of actual data on human test subjects that would lead anyone to the conclusion that they have a working diagnostics system in line with what they have claimed and what you have inferred.

If they actually had such data - Korean or otherwise - they would not be sitting on it. Because - leaving aside the FDA- it's effect would be to make multi-millionaires of everyone associated with the company, overnight, and launch a stampede of major health companies to launch and manufacture the technology. It would have been on CNN in fact!

But it simply doesn't exist!

[Going_4_It]

The OTC market did not have these shorting problem until they removed the Up-Tick Rule in 2007

After that it has been an occasional blood-bath...

The uptick rule was a rule from the Securities and Exchange Commission that prevented short sellers from putting more pressure on a security that was already languishing.

The uptick rule is a trading restriction that states that short selling a stock is only allowed on an uptick. Short sales were not permitted on minus ticks or zero-minus ticks, subject to narrow exceptions." The rule went into effect in 1938 and was removed when Rule 201 Regulation SHO became effective in 2007.